Free ACG Clinical Guidelines Questions and Answers

Question 1

According to ACG guidelines, which of the following is the recommended first-line treatment for Helicobacter pylori infection in a patient with no history of macrolide exposure?

Accepted Answer

Clarithromycin triple therapy

Answer

According to ACG guidelines, clarithromycin triple therapy (PPI, clarithromycin, and amoxicillin or metronidazole) is recommended as a first-line treatment for H. pylori infection in patients with no prior macrolide exposure. This regimen is effective in eradicating the bacteria when clarithromycin resistance rates are low. It provides a balanced approach to treatment by combining acid suppression with two antibiotics.

Question 2

For patients with Barrett’s esophagus without dysplasia, what is the recommended surveillance interval according to ACG guidelines?

Accepted Answer

Every 3-5 years

Answer

ACG guidelines recommend endoscopic surveillance with biopsies every 3-5 years for patients diagnosed with Barrett's esophagus without dysplasia. This interval is considered appropriate for monitoring the condition and detecting any progression, such as the development of dysplasia, while avoiding overly frequent and unnecessary procedures. Regular surveillance helps manage the risk of esophageal adenocarcinoma.

Question 3

According to ACG guidelines, what is the recommended first-line therapy for inducing remission in patients with moderate to severe Crohn's disease?

Accepted Answer

Anti-TNF agents (e.g., infliximab)

Answer

For patients with moderate to severe Crohn's disease, ACG guidelines recommend anti-TNF agents (e.g., infliximab) as the first-line therapy for inducing remission. These biologic medications target specific inflammatory pathways, offering potent and sustained control of the disease. They are more effective than traditional therapies like 5-ASAs or corticosteroids for achieving deep remission in more severe cases.

Question 4

According to ACG guidelines, which of the following is the preferred test for initial evaluation of suspected celiac disease?

Accepted Answer

Anti-tissue transglutaminase (anti-tTG) IgA antibodies

Answer

The anti-tissue transglutaminase (anti-tTG) IgA antibody test is the preferred initial screening test for suspected celiac disease, according to ACG guidelines. This test has high sensitivity and specificity, making it a reliable first step in identifying individuals who may have celiac disease. A positive result typically warrants further confirmatory testing, such as an endoscopic biopsy of the small intestine.

Question 5

According to ACG guidelines, which of the following screening intervals is recommended for patients with average risk for colorectal cancer, beginning at age 45?

Accepted Answer

Fecal immunochemical test (FIT) annually

Answer

For average-risk individuals beginning at age 45, ACG guidelines recommend several options for colorectal cancer screening. Among the non-invasive methods, the Fecal Immunochemical Test (FIT) is recommended annually. FIT is an effective and convenient test for detecting occult blood in stool, which can be an indicator of polyps or colorectal cancer.

ACG - American College of Gastroenterology Practice Test

ACG - American College of Gastroenterology Practice Test

Free ACG Clinical Guidelines Questions and Answers